Dr. Bart Geerts is co-founder and CEO, and a trained anaesthesiologist, intensivist and clinical pharmacologist with a focus on AI-driven perioperative risk prediction and proactive surgical care. He has worked at leading hospitals including University College London Hospitals (UCLH), Amsterdam UMC and Spaarne Gasthuis, where he helped teams use routine clinical data to better predict post-operative infections and other complications.

Bart holds an MSc in Biomedical Sciences, an MD, a PhD in intensive care medicine and an MBA from IE University in Madrid, combining deep clinical expertise with data-science-driven product development and healthcare entrepreneurship. He previously collaborated with Edwards Lifesciences, Scyfer (now part of Qualcomm) and Philips on bringing AI healthtech tools into daily clinical workflows.

He is (co)author of more than 100 scientific publications in high-impact journals and speaks frequently on responsible use of AI in surgery and critical care. Bart currently serves as chair of the AI committee of the Dutch Federation of Medical Specialists (FMS), helping shape national guidance for safe and effective clinical AI.